# A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

> **NCT02606214** · PHASE1 · TERMINATED · sponsor: **Global Alliance for TB Drug Development** · enrollment: 18 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** TBA-354
- **DRUG:** TBA-354 Placebo

## Key facts

- **NCT ID:** NCT02606214
- **Lead sponsor:** Global Alliance for TB Drug Development
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11
- **Primary completion:** 2015-12
- **Final completion:** 2016-12
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Clinical Hold from FDA
- **Last updated:** 2019-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02606214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02606214, "A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02606214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*